Leysen, D.; Kelder, J. (1998). Ligands for the 5-HT2C receptor as potential antidepressants and anxiolytics. 29. pp. 49–61. DOI:10.1016/S0165-7208(98)80044-5.
Shimada, I; Maeno, K; Kazuta, K; Kubota, H; Kimizuka, T; Kimura, Y; Hatanaka, K; Naitou, Y i dr.. (2008). „Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo2,3-gindazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists”. Bioorganic & medicinal chemistry16 (4): 1966–82. DOI:10.1016/j.bmc.2007.10.100. PMID18035544.
Albertini S, Bös M, Gocke E, Kirchner S, Muster W, Wichmann J. Suppression of mutagenic activity of a series of 5HT2c receptor agonists by the incorporation of a gem-dimethyl group: SAR using the Ames test and a DNA unwinding assay. Mutagenesis. 1998 Jul;13(4):397-403. PMID9717178
ncbi.nlm.nih.gov
Shimada, I; Maeno, K; Kazuta, K; Kubota, H; Kimizuka, T; Kimura, Y; Hatanaka, K; Naitou, Y i dr.. (2008). „Synthesis and structure-activity relationships of a series of substituted 2-(1H-furo2,3-gindazol-1-yl)ethylamine derivatives as 5-HT2C receptor agonists”. Bioorganic & medicinal chemistry16 (4): 1966–82. DOI:10.1016/j.bmc.2007.10.100. PMID18035544.
